Calmer Life: Testing the Effectiveness of a Treatment for Anxiety
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The overall goals of the proposed research study are to: (1) examine quantitative outcomes in a well-conducted randomized clinical trial of Calmer Life, relative to Enhanced Community Care, an information and referral intervention that represents care in a real-world community-service environment, and (2) evaluate implementation feasibility, which includes training community providers; examining program reach, engagement, acceptability, and barriers-facilitators; and preparing practical tools for replicating the program.
| Condition | Intervention |
|---|---|
|
Generalized Anxiety Disorder Anxiety Disorder NOS |
Behavioral: CBT Other: ECC |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Calmer Life: A Randomized Controlled Trial of a Participant-Centered Treatment for Anxiety in Low-Income, Older Adults |
- Geriatric Anxiety Inventory [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Penn State Worry Questionnaire (PSWQ-A) [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Generalized Anxiety Disorder-7 [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Patient Health Questionnaire-9 [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Insomnia Severity Index [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Late-Life Functional Disability Index [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- SF-12 Health Survey [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Client Satisfaction Questionnaire [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Brief RCOPE [ Time Frame: 3 months ] [ Designated as safety issue: No ]Religious coping
- Health services use [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Use of psychotropic medication [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Brief Multidimensional Measure of Religiousness and Spirituality [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Satisfaction with Life Scale [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Geriatric Depression Scale [ Time Frame: 3 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 60 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: CBT |
Behavioral: CBT
6-12 sessions of CBT in person or over the phone
Other Name: Cognitive Behavior Treatment, Cognitive Behavior Therapy
|
| Active Comparator: Enhanced Community Care (ECC) |
Other: ECC
6 biweekly sessions of ECC over the telephone
Other Name: Enhanced Community Care
|
Detailed Description:
Cognitive behavioral treatment (CBT) produces positive outcomes for late-life worry/GAD in academic and primary care settings, but minorities are significantly underrepresented in clinical trials, and standard CBT poorly addresses the needs of low-income minority older adults in underserved communities. More attention needs to be given to service delivery of anxiety treatments for underserved older adults. Calmer Life (CL) is a culturally tailored, participant-centered research study that offers a skills-based intervention for late-life anxiety and includes other elements of care to meet the needs of underserved, minority older adults, including the option to integrate religion/spirituality (R/S), flexible delivery modes, and modular treatment format.
Participants will be randomly assigned to CL or Enhanced Community Care(ECC). CL and ECC will be provided by behavioral health clinicians recruited from partner organizations, psychology trainees, and other research staff over 3 months. Assessments will occur at baseline and 3 months.
Participants in the CL condition can choose up to 12 individual skill sessions, and will be recommended to complete a minimum of 6 sessions. If participants desire to incorporate R/S, an R/S assessment occurs during session 2 to help the provider understand the participant's beliefs and practices. R/S can be integrated into any of the skills learned during the intervention (e.g., deep breathing, self-statements, sleep management) or omitted entirely.
Participants in the ECC condition will receive brief biweekly check in calls to provide information about community resources (including mental health), offer emotional support, and assess symptom severity and need for crisis intervention. Emergency procedures will be followed in crisis situations. After 3 months of ECC is completed, participants in the ECC group will be offered the CL intervention.
Outcome measures will be administered for participants in both groups at baseline, 1 month, and 3 months. Participants in ECC will complete measures at 6 months after completion of CL.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 50 and older
- Principal or Co-principal diagnosis of GAD or ADNOS
- Must speak English
- Must have a health care or social service provider and provide written authorization to research team to communicate with their health-care or social service provider
- Must live, work, worship, attend community functions, and/or receive health care in target geographic areas
Exclusion Criteria:
- Active suicidal intent
- Current psychosis
- Mania or substance abuse within the last month
- Cognitive impairment according to a Mini Cog screener score of 3 or lower
Contacts and Locations| Contact: Melinda A Stanley, PhD | 713-794-8832 | mstanley@bcm.edu |
| Contact: Paula Wagener, BA | 713-794-8831 | pwagener@bcm.edu |
| United States, Texas | |
| Houston Center for Quality of Care and Utilization Studies | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Melinda A Stanley, PhD 713-794-8832 mstanley@bcm.edu | |
| Contact: Paula Wagener, BA 713-794-8831 pwagener@bcm.edu | |
| Principal Investigator: | Melinda A Stanley, PhD | Baylor College of Medicine |
More Information
No publications provided
| Responsible Party: | Melinda Stanley, Professor, Baylor College of Medicine |
| ClinicalTrials.gov Identifier: | NCT01702220 History of Changes |
| Other Study ID Numbers: | H30928 |
| Study First Received: | October 4, 2012 |
| Last Updated: | March 27, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Baylor College of Medicine:
|
Generalized Anxiety Disorder Geriatric |
Additional relevant MeSH terms:
|
Anxiety Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013